Literature DB >> 15671251

Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats.

Andrei I Ivanov1, Alexandre A Steiner, Adrienne C Scheck, Andrej A Romanovsky.   

Abstract

Erythropoietin-producing hepatocellular (Eph) receptor tyrosine kinases and their ligands, ephrins, are involved in embryogenesis and oncogenesis by mediating cell adhesion and migration. Although ephrins can be induced by bacterial LPS in vitro, whether they are involved in inflammation in vivo is unknown. Using differential mRNA display, we found that a febrigenic dose of LPS (50 microg/kg iv) induces a strong transcriptional upregulation of ephrin-A1 in rat liver. We confirmed this finding by real-time RT-PCR. We then quantified the mRNA expression of different ephrins and Eph receptors at phases 1-3 of LPS fever in different organs. Febrile phases 2 (90 min post-LPS) and 3 (300 min) were characterized by robust upregulation (up to 16-fold) and downregulation (up to 21-fold) of several ephrins and Eph receptors. With the exception of EphA2, which showed upregulation in the brain at phase 2, expressional changes of Eph receptors and ephrins were limited to the LPS-processing organs: liver and lung. Characteristic, counter-directed changes in expressional regulation of Eph receptors and their corresponding ligands were found: upregulation of EphA2, downregulation of ephrin-A1 in the liver and lung at phase 2; downregulation of EphB3, upregulation of ephrin-B2 in the liver at phase 2; downregulation of EphA1 and EphA3, upregulation of ephrins-A1 and -A3 in liver at phase 3. In the liver, transcriptional changes of EphA2 and EphB3 at phase 2 were confirmed at protein level. These coordinated, phase-specific responses suggest that different sets of ephrins and Eph receptors may be involved in cellular events (such as disruption of tissue barriers and leukocyte transmigration) underlying different stages of systemic inflammatory response to LPS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15671251     DOI: 10.1152/physiolgenomics.00043.2004

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  22 in total

Review 1.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

2.  EphA2 stimulates VCAM-1 expression through calcium-dependent NFAT1 activity.

Authors:  Steven Daniel Funk; Alexandra C Finney; Arif Yurdagul; Christopher B Pattillo; A Wayne Orr
Journal:  Cell Signal       Date:  2018-05-21       Impact factor: 4.315

3.  The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice.

Authors:  Patrice N Mimche; Lauren M Brady; Christian F Bray; Choon M Lee; Manoj Thapa; Thayer P King; Kendra Quicke; Courtney D McDermott; Sylvie M Mimche; Arash Grakoui; Edward T Morgan; Tracey J Lamb
Journal:  Hepatology       Date:  2015-04-22       Impact factor: 17.425

4.  Eph-A2 promotes permeability and inflammatory responses to bleomycin-induced lung injury.

Authors:  Todd C Carpenter; William Schroeder; Kurt R Stenmark; Eric P Schmidt
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

5.  Age-related Notch-4 quiescence is associated with altered wall remodeling during vein graft adaptation.

Authors:  Yuka Kondo; Akihito Muto; Fabio A Kudo; Lynn Model; Sammy Eghbalieh; Paraag Chowdhary; Alan Dardik
Journal:  J Surg Res       Date:  2011-07-19       Impact factor: 2.192

6.  Erythropoietin-producing hepatocellular receptor B2 receptor tyrosine kinase: A novel regulator of infection- and inflammation-induced liver fibrosis.

Authors:  Noah S Butler; Nathan W Schmidt
Journal:  Hepatology       Date:  2015-05-26       Impact factor: 17.425

7.  Receptor tyrosine kinase EphA2 mediates thrombin-induced upregulation of ICAM-1 in endothelial cells in vitro.

Authors:  Barden Chan; Vikas P Sukhatme
Journal:  Thromb Res       Date:  2008-09-03       Impact factor: 3.944

Review 8.  Eph/ephrin signaling in epithelial development and homeostasis.

Authors:  Hui Miao; Bingcheng Wang
Journal:  Int J Biochem Cell Biol       Date:  2008-08-09       Impact factor: 5.085

9.  Endothelial EphA receptor stimulation increases lung vascular permeability.

Authors:  Jacqueline Larson; Stacey Schomberg; William Schroeder; Todd C Carpenter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-03       Impact factor: 5.464

10.  EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia.

Authors:  Melissa A Cercone; William Schroeder; Stacey Schomberg; Todd C Carpenter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-14       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.